Clinical Breast Cancer (@cbcjournal) 's Twitter Profile
Clinical Breast Cancer

@cbcjournal

Official account of CBC, a journal publishing 8 issues/year on various aspects of clinical & translational breast cancer research. IF 3.225 | RTs ≠ endorsement.

ID: 1503470749612396544

linkhttp://clinical-breast-cancer.com calendar_today14-03-2022 20:39:09

118 Tweet

310 Followers

408 Following

Palliative Research Center (@pittpalcare) 's Twitter Profile Photo

ICYMI: What's the relationship b/t economic hardship & symptom distress for breast cancer patients prior to initiation of treatment? Read Margaret Rosenzweig's recent study on economic hardship in breast cancer patients, in print Clinical Breast Cancer: #hapc #pallcareresearch #nursetwitter

ICYMI: What's the relationship b/t economic hardship &amp; symptom distress for breast cancer patients prior to initiation of treatment? Read <a href="/MargaretRosenzw/">Margaret Rosenzweig</a>'s recent study on economic hardship in breast cancer patients, in print <a href="/CBCjournal/">Clinical Breast Cancer</a>: #hapc #pallcareresearch #nursetwitter
Clinical Breast Cancer (@cbcjournal) 's Twitter Profile Photo

Dry Heat Treatment (Fluidotherapy) added to complete decongestive therapy lead to reduced pain and edema severity in patients with breast cancer related lymphedema. Read more about study 👇 #bcsm #CBCjournal pubmed.ncbi.nlm.nih.gov/38565462/

Dry Heat Treatment (Fluidotherapy) added to complete decongestive therapy lead to reduced pain and edema severity in patients with breast cancer related lymphedema. Read more about study 👇

#bcsm #CBCjournal

pubmed.ncbi.nlm.nih.gov/38565462/
Clinical Breast Cancer (@cbcjournal) 's Twitter Profile Photo

The Importance of Naming Structural Racism as a Root Cause of Racial Inequities in Breast Cancer Outcomes👇 #bcsm #RacialDisparities #CBCjournal Sydney Habert, MD clinical-breast-cancer.com/article/S1526-…

Clinical Breast Cancer (@cbcjournal) 's Twitter Profile Photo

Study 🚨highlighting an opportunity to identify candidates for axillary de-escalation, potentially reducing morbidity and tailoring treatment more closely to individual patient needs. Read 👇 #bcsm #CBCjournal Boston Breast Surgeon Samir Mitri, MD clinical-breast-cancer.com/article/S1526-…

Clinical Breast Cancer (@cbcjournal) 's Twitter Profile Photo

A phase I study of alpelisib + capecitabine in pts with MBC showed that combination is safe and well-tolerated oral regimen. Treatment responses were observed regardless of HR and PIK3CA status. Read more👇 #bcsm Yara Abdou, MD, MSCR Carey Anders Lisa Carey, MD, ScM, FASCO sciencedirect.com/science/articl…

A phase I study of alpelisib + capecitabine in pts with MBC showed that combination is safe and well-tolerated oral regimen. Treatment responses were observed regardless of HR and PIK3CA status.  

Read more👇 #bcsm
<a href="/YAbdouMD/">Yara Abdou, MD, MSCR</a> <a href="/CareyAnders1/">Carey Anders</a>  <a href="/DrLisaCarey/">Lisa Carey, MD, ScM, FASCO</a> 

sciencedirect.com/science/articl…
Clinical Breast Cancer (@cbcjournal) 's Twitter Profile Photo

Axillary involvement is linked to increased risk of distant metastasis, read more about metastatic mechanisms sciencedirect.com/science/articl… Figure👇 illustrates the intricate mechanisms of programming the SLN microenvironment to become a metastatic niche. Professor Kefah Mokbel The Princess Grace Hospital #bcsm

Axillary involvement is linked to increased risk of distant metastasis, read more about metastatic mechanisms 
sciencedirect.com/science/articl…

Figure👇 illustrates the intricate mechanisms of  programming the SLN microenvironment to become a metastatic niche.

<a href="/KefahMokbel/">Professor Kefah Mokbel</a> <a href="/PGHosp/">The Princess Grace Hospital</a> #bcsm
Simeone D'Ambrosio (@dambrosiosime) 's Twitter Profile Photo

Check out on Clinical Breast Cancer our review of comparative evidence from clinical studies with metronomic versus standard-dose regimens. Dario Trapani Elena Battaiotto clinical-breast-cancer.com/article/S1526-…

Check out on <a href="/CBCjournal/">Clinical Breast Cancer</a> our review of comparative evidence from clinical studies with metronomic versus standard-dose regimens.
<a href="/darioT_/">Dario Trapani</a> <a href="/BattaiottoElena/">Elena Battaiotto</a> 

clinical-breast-cancer.com/article/S1526-…
Neiman HPI (@neimanhpi) 's Twitter Profile Photo

A new study in Clinical Breast Cancer shows mobile #mammography helps increase breast cancer screening in underserved areas, especially among Indigenous, rural, & low-income women. It complements facility-based screenings and improves early detection. #HealthEquity bit.ly/HPI_MobileMammo

Clinical Breast Cancer (@cbcjournal) 's Twitter Profile Photo

A Clinical Review of Subcutaneous (SC) Trastuzumab and Pertuzumab in treating early-stage and metastatic HER2+ BC, highlighting benefits of SC vs IV formulations. Check out more 👇 Antoinette Tan, MD, MHSc, FACP, FASCO @levinecancer Atrium Health #bcsm #CBCjournal pubmed.ncbi.nlm.nih.gov/39567339/

Clinical Breast Cancer (@cbcjournal) 's Twitter Profile Photo

NH Black women have ⬆️ risk of TNBC yet, they are less likely to undergo genetic counseling / testing and less likely to receive guideline-directed screening and risk-reduction compared to NH White women. #bcsm #disparities Demetria Smith-Graziani, MD, MPH Winship Cancer Institute of Emory University pubmed.ncbi.nlm.nih.gov/39477723/

Clinical Breast Cancer (@cbcjournal) 's Twitter Profile Photo

A Clinical Review of the Role of Immunotherapy in TNBC, with an Overview of Data from Seminal Trials for both Early and Advanced TNBC. #bcsm Rita Nanda UChicago Medicine pubmed.ncbi.nlm.nih.gov/38582617/

A Clinical Review of the Role of Immunotherapy in TNBC, with an Overview of Data from Seminal Trials for both Early and Advanced TNBC.

#bcsm
<a href="/RitaNandaMD/">Rita Nanda</a> <a href="/UChicagoMed/">UChicago Medicine</a>

pubmed.ncbi.nlm.nih.gov/38582617/
Dana-Farber’s Breast Oncology Center (@dfci_breastonc) 's Twitter Profile Photo

🔔Hot off the press! Optimizing Postneoadjuvant Treatment of Residual #BreastCancer With Adjuvant Bevacizumab Alone, With Metronomic or Standard-Dose Chemotherapy 🔓Free access until 03/21: sciencedirect.com/science/articl… ✍️Clinical Breast Cancer Dario Trapani Qingchun Jin Hope Rugo Yara Abdou, MD, MSCR

🔔Hot off the press! Optimizing Postneoadjuvant Treatment of Residual #BreastCancer With Adjuvant Bevacizumab Alone, With Metronomic or Standard-Dose Chemotherapy
🔓Free access until 03/21: sciencedirect.com/science/articl…
✍️<a href="/CBCjournal/">Clinical Breast Cancer</a> <a href="/darioT_/">Dario Trapani</a> <a href="/JinQingchun/">Qingchun Jin</a> <a href="/hoperugo/">Hope Rugo</a>
<a href="/YAbdouMD/">Yara Abdou, MD, MSCR</a>
Clinical Breast Cancer (@cbcjournal) 's Twitter Profile Photo

A study evaluating forequarter amputation (FA) in BC (locally advanced/recurrent tumor, Stewart & Treves syndrome, radiation-induced sarcoma) showed that FA has few complications & attenuates symptoms in pts tx with both curative & palliative intent. sciencedirect.com/science/articl…

A study evaluating forequarter amputation (FA) in BC (locally advanced/recurrent tumor, Stewart &amp; Treves syndrome, radiation-induced sarcoma)  showed that FA has few complications &amp; attenuates symptoms in pts tx with both curative &amp; palliative intent.

sciencedirect.com/science/articl…
Clinical Breast Cancer (@cbcjournal) 's Twitter Profile Photo

Radiation omission in pts w/ early BC is a dynamically changing paradigm. Individualizing treatment is paramount and understanding an individual pt's goals of treatments and values is key. Read more 👇 #bcsm Roswell Park Simon Fung-Kee-Fung MD Mark Farrugia Chirag Shah clinical-breast-cancer.com/article/S1526-…

Clinical Breast Cancer (@cbcjournal) 's Twitter Profile Photo

PreciseDx Breast is a digital risk assessment test that predicts early BC recurrence within 6-years of diagnosis. Read more👇 #bcsm Icahn School of Medicine at Mount Sinai clinical-breast-cancer.com/article/S1526-…

PreciseDx Breast is a digital risk assessment test that predicts early BC recurrence within 6-years of diagnosis. Read more👇
#bcsm  <a href="/IcahnMountSinai/">Icahn School of Medicine at Mount Sinai</a> 
clinical-breast-cancer.com/article/S1526-…